Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

Overview

Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy

Full Title of Study: “Evaluation of Retinal Structure With High Resolution OCT”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: November 27, 2023

Detailed Description

Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy

Interventions

  • Other: Examination with an OCT device

Arms, Groups and Cohorts

  • 1
    • Healthy volunteers
  • 2
    • CSME secondary to diabetic retinopathy
  • 3
    • ARMD with CNV before and after therapy
  • 4
    • ARMD atrophic
  • 5
    • Retinal vein occlusion
  • 6
    • retinitis pigmentosa
  • 7
    • vitreoretinal proliferation

Clinical Trial Outcome Measures

Primary Measures

  • Integrity of retinal layers
    • Time Frame: End of study

Participating in This Clinical Trial

Inclusion Criteria

  • Macular disease – Healthy subjects

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Sebastian Wolf
  • Collaborator
    • University of Bern
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Sebastian Wolf, Director – Insel Gruppe AG, University Hospital Bern
  • Overall Official(s)
    • Sebastian Wolf, MD, PhD, Principal Investigator, University of Bern
    • Sebastian Wolf, MD PhD, Study Director, University of Bern

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.